Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics cash
Cash and short-term investments held at the end of each period.
Endonovo Therapeutics's cash was $0 at Sep 30, 2023. For fiscal 2022 it was $98, down 99.9% from the year before. Over ten years it grew -18.9% a year on average. The highest annual figure on record is $379.15K in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $98 | -99.9% |
| FY2021 | Dec 31, 2021 | $85.94K | +540.4% |
| FY2020 | Dec 31, 2020 | $13.42K | -29.0% |
| FY2019 | Dec 31, 2019 | $18.89K | -95.0% |
| FY2018 | Dec 31, 2018 | $379.15K | +320.5% |
| FY2017 | Dec 31, 2017 | $90.17K | +62.4% |
| FY2016 | Dec 31, 2016 | $55.53K | +33.9% |
| FY2015 | Dec 31, 2015 | $41.47K | +4097.7% |
| FY2014 | Dec 31, 2014 | $988 | -69.6% |
| FY2013 | Dec 31, 2013 | $3.26K | +306.9% |
| FY2012 | Dec 31, 2012 | $800 | -91.3% |
| FY2011 | Dec 31, 2011 | $9.25K | – |
| FY2010 | Dec 31, 2010 | $0 | -100.0% |
| FY2009 | Dec 31, 2009 | $49.24K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $32.60K | – |
| Q1 FY2023 | Mar 31, 2023 | $10.94K | -81.8% |
| Q4 FY2022 | Dec 31, 2022 | $98 | -99.9% |
| Q3 FY2022 | Sep 30, 2022 | $23.14K | +303.7% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $59.98K | -30.2% |
| Q4 FY2021 | Dec 31, 2021 | $85.94K | +540.4% |
| Q3 FY2021 | Sep 30, 2021 | $5.73K | +121.9% |
| Q2 FY2021 | Jun 30, 2021 | $8.54K | +62.4% |
| Q1 FY2021 | Mar 31, 2021 | $85.97K | +48198.9% |
| Q4 FY2020 | Dec 31, 2020 | $13.42K | -29.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.58K | -48.7% |
| Q2 FY2020 | Jun 30, 2020 | $5.26K | -99.0% |
| Q1 FY2020 | Mar 31, 2020 | $178 | -99.7% |
| Q4 FY2019 | Dec 31, 2019 | $18.89K | -95.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.04K | -99.2% |
| Q2 FY2019 | Jun 30, 2019 | $547.53K | +709.7% |
| Q1 FY2019 | Mar 31, 2019 | $58.48K | -38.6% |
| Q4 FY2018 | Dec 31, 2018 | $379.15K | +320.5% |
| Q3 FY2018 | Sep 30, 2018 | $665.24K | +931.7% |
| Q2 FY2018 | Jun 30, 2018 | $67.62K | +182.4% |
| Q1 FY2018 | Mar 31, 2018 | $95.30K | -15.6% |
| Q4 FY2017 | Dec 31, 2017 | $90.17K | +62.4% |
| Q3 FY2017 | Sep 30, 2017 | $64.48K | -31.9% |
| Q2 FY2017 | Jun 30, 2017 | $23.94K | -69.6% |
| Q1 FY2017 | Mar 31, 2017 | $112.93K | +172.3% |
| Q4 FY2016 | Dec 31, 2016 | $55.53K | +116.5% |
| Q3 FY2016 | Sep 30, 2016 | $94.68K | +9482.5% |
| Q1 FY2016 | Jun 30, 2016 | $78.69K | +53.7% |
| Q4 FY2015 | Dec 31, 2015 | $41.47K | -71.4% |
| Q1 FY2015 | Mar 31, 2015 | $25.65K | -67.8% |
| Q4 FY2014 | Dec 31, 2014 | $988 | -69.6% |
| Q3 FY2014 | Sep 30, 2014 | $51.19K | +4137.5% |
| Q2 FY2014 | Jun 30, 2014 | $144.98K | +6681.2% |
| Q1 FY2014 | Mar 31, 2014 | $79.65K | +143.2% |
| Q4 FY2013 | Dec 31, 2013 | $3.26K | – |
| Q3 FY2013 | Sep 30, 2013 | $1.21K | – |
| Q2 FY2013 | Jun 30, 2013 | $2.14K | – |
| Q1 FY2013 | Mar 31, 2013 | $32.75K | – |
See a number that looks wrong?